Open Peer Review Reports for: Long-term use of lenalidomide and low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: MM-024 Extended Access Program
Pre-publication versions of this article are available by contacting info@biomedcentral.com.
| Original Submission | ||
|---|---|---|
| 6 Sep 2015 | Submitted | Original manuscript |
| 19 Sep 2015 | Reviewed | Reviewer Report - John Densmore |
| 29 Sep 2015 | Reviewed | Reviewer Report - Tamila Kindwall-Keller |
| 9 Nov 2015 | Author responded | Author comments - Xin Du |
| Resubmission - Version 2 | ||
| 9 Nov 2015 | Submitted | Manuscript version 2 |
| 22 Dec 2015 | Author responded | Author comments - Xin Du |
| Resubmission - Version 3 | ||
| 22 Dec 2015 | Submitted | Manuscript version 3 |
| Publishing | ||
| 17 Jan 2016 | Editorially accepted | |
| 28 Jan 2016 | Article published | 10.1186/s12885-016-2069-8 |
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.
You can find further information about the peer review system here.
